AstraZeneca's playbook to break into the red-hot obesity market rests on improving upon existing medicines, offering competitive prices and leaning on its experience selling products in emerging markets https://www.bloomberg.com/news/articles/2026-02-10/astrazeneca-s-obesity-plan-look-beyond-us-embrace-low-prices?taid=698b397ba4535d0001d66b84&utm_campaign=trueanthem&utm_content=business&utm_medium=social&utm_source=twitter